Who should consider PGD for Anueploidy?
The clinical benefits of PGD are an active area of research. Aneuploidy can occur in any embryo from any couple just by chance, although some couples are at a higher risk. A number of studies using FISH, which until recently had been the industry standard, have demonstrated that PGD may be particularly beneficial for couples meeting any of the criteria below. Traditional FISH testing has known limitations; thus, given the recent advances in PGD technology, including the ability to deliver results on all 24 chromosomes with high levels of accuracy, an even greater benefit from PGD is expected with these newer testing methods. Due to the fact that these technologies are new, clinical data is still pending.
